CLAB ONCOLOGY

clab-oncology-logo

CLab Oncology is a biotechnology company

#SimilarOrganizations #Website #More

CLAB ONCOLOGY

Industry:
Biotechnology

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.curelaboncology.com

Total Employee:
1+

Status:
Active

Contact:
609-841-1201

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins


Similar Organizations

celprogen-logo

Celprogen

Celprogen is a biotechnology company.

genosco-logo

Genosco

Genosco is a biotechnology company.

igf-oncology-logo

IGF Oncology

IGF Oncology is a biotech company

nanosomix-logo

NanoSomiX

NanoSomiX is a biotechnology company

Official Site Inspections

http://www.curelaboncology.com Semrush global rank: 6.06 M Semrush visits lastest month: 1.34 K

  • Host name: proxy-2.default-host.net
  • IP address: 185.68.16.27
  • Location: Ukraine
  • Latitude: 50.4522
  • Longitude: 30.5287
  • Timezone: Europe/Kiev

Loading ...

More informations about "CLab Oncology"

ADVISORY BOARD โ€“ CureLab Oncology

โ˜… David Shulkin, MD In the past served as the 9th US Secretary of Veterans Affairs, President & CEO of Beth Israel Medical Center, President of Morristown Medical Center and VP of Atlantic โ€ฆSee details»

CureLab Oncology โ€“ CureLab Oncology is a biotechnology โ€ฆ

CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics. CureLab Oncology is committed to creating a family of revolutionarySee details»

CureLab Oncology, Inc. - Drug pipelines, Patents, Clinical trials

Explore CureLab Oncology, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 3 news, and 15 literature, Disease Domain ...See details»

In the news - CureLab Oncology

Sep 29, 2023 The leading professional organization for medical oncology has selected two research presentations authored by CureLabโ€™s science team, which is currently conducting โ€ฆSee details»

CureLab Oncology - LinkedIn

CureLab Oncology | 465 followers on LinkedIn. Revolutionary therapies that prolong lives. | CureLab Oncology is a biotechnology company developing new anti-cancer biologics. CureLab Oncology is ...See details»

CureLab Oncology Overview | SignalHire Company Profile

Organization Website: curelaboncology.com : CureLab Oncology industries Biotech: Headquarters Location: Boston, Massachusetts, 02138 US Boston, Massachusetts, 0213...See details»

CureLab Oncology - Crunchbase Company Profile

Curelaboncology.com ; 53,992; Highlights. obfuscated. Total Funding Amount . Unlock for free . Contacts 1. Employee Profiles 1. ... Which industries do these Sub-Organization operate in? Show . Curelab Veterinary Subsidiary. โ€ฆSee details»

CureLab Oncology, Inc. - VentureRadar

CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics. CureLab Oncology is committed to creating a family of... ... Find out more ...See details»

Nextsource | Company Profile | CureLab Oncology

Explore the company profile of CureLab Oncology (curelaboncology.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»

CureLab Oncology - Overview, Competitors, and โ€ฆ

CureLab Oncology is a biotechnology company developing new anti-cancer biologics. CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives.\Our Lead โ€ฆSee details»

CureLab Oncology Company Profile | Management and Employees โ€ฆ

Www.curelaboncology.com . CureLab Oncology Profile and History. CureLab Oncology Inc. is a clinical-stage immuno-oncology biotech company headquartered in the greater Boston area. โ€ฆSee details»

Curelab Oncology - PitchBook

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; AU-2022441199-A1: Prevention and treatment of diseases by modulating activity of mesenchymal stem cells โ€ฆSee details»

CureLab Oncology Inc Overview - Salary.com

Discover essential details about CureLab Oncology Inc, including address, contact, and journey of our company's evolution.See details»

CureLab Oncology Appoints Dr. Aubrey C. Galloway as Chief โ€ฆ

BOSTON โ€“ July 11, 2024: CureLab Oncologya clinical-stage biotech company, has appointed Dr. Aubrey C. Galloway as chief medical officer. This strategic move follows Dr. Gallowayโ€™s recent โ€ฆSee details»

CureLab Oncology

The mission of CureLab Oncology is to develop novel anti-cancer therapies to help prolong the lives of patients. Interestingly, CureLab also performs veterinary research to treat dogs and โ€ฆSee details»

CureLab Oncology - Overview, News & Similar companies

Oct 2, 2018 View CureLab Oncology (www.curelaboncology.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well โ€ฆSee details»

CureLab Oncology Seeks to Revolutionize Chronic Pain โ€ฆ

Nov 14, 2024 Patent application paves the way for a potential breakthrough in chronic pain treatment, offering renewed hope for millions. BOSTON, Nov. 14, 2024 /PRNewswire/ -- โ€ฆSee details»

New approach to fertility preservation offers young cancer โ€ฆ

17 hours ago Kelly Wilson Cull, director of advocacy for the Canadian Cancer Society, said her organization is urging provincial and territorial governments to publicly fund ovarian tissue โ€ฆSee details»

CureLab Oncology welcomes Dr. Aubrey C. Galloway as chief โ€ฆ

Oct 21, 2024 In an article titled "CureLab Oncology Appoints Dr. Aubrey C. Galloway as Chief Medical Officer," BioSpace reports on the company's strategic appointment of Dr. Galloway to โ€ฆSee details»

CureLab Oncology's CEO shares Insights on biotech โ€ฆ

Jul 11, 2024 In the Labiotech.eu article titled "How to Build Your Biotech Company in 2024 (According to Founders)," Dr. Alexander Shneider, CEO of CureLab Oncology, likens the โ€ฆSee details»

linkstock.net © 2022. All rights reserved